Will Quick Heal Technologies (NSE:QUICKHEAL) Multiply In Value Going Forward?

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, and secondly, an expanding base of capital employed. Put simply, these types of businesses are compounding machines, meaning they are continually reinvesting their earnings at ever-higher rates of return. However, after investigating Quick Heal Technologies (NSE:QUICKHEAL), we don't think it's current trends fit the mold of a multi-bagger.

Advertisement

What is Return On Capital Employed (ROCE)?

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. To calculate this metric for Quick Heal Technologies, this is the formula:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.13 = ₹896m ÷ (₹7.3b - ₹634m) (Based on the trailing twelve months to June 2020).

So, Quick Heal Technologies has an ROCE of 13%. That's a relatively normal return on capital, and it's around the 12% generated by the Software industry.

Check out our latest analysis for Quick Heal Technologies

roce
NSEI:QUICKHEAL Return on Capital Employed October 16th 2020

While the past is not representative of the future, it can be helpful to know how a company has performed historically, which is why we have this chart above. If you're interested in investigating Quick Heal Technologies' past further, check out this free graph of past earnings, revenue and cash flow.

What Does the ROCE Trend For Quick Heal Technologies Tell Us?

When we looked at the ROCE trend at Quick Heal Technologies, we didn't gain much confidence. Over the last five years, returns on capital have decreased to 13% from 18% five years ago. Meanwhile, the business is utilizing more capital but this hasn't moved the needle much in terms of sales in the past 12 months, so this could reflect longer term investments. It's worth keeping an eye on the company's earnings from here on to see if these investments do end up contributing to the bottom line.

On a side note, Quick Heal Technologies has done well to pay down its current liabilities to 8.6% of total assets. So we could link some of this to the decrease in ROCE. Effectively this means their suppliers or short-term creditors are funding less of the business, which reduces some elements of risk. Some would claim this reduces the business' efficiency at generating ROCE since it is now funding more of the operations with its own money.

The Key Takeaway

To conclude, we've found that Quick Heal Technologies is reinvesting in the business, but returns have been falling. And with the stock having returned a mere 1.7% in the last three years to shareholders, you could argue that they're aware of these lackluster trends. So if you're looking for a multi-bagger, the underlying trends indicate you may have better chances elsewhere.

One more thing, we've spotted 2 warning signs facing Quick Heal Technologies that you might find interesting.

While Quick Heal Technologies isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

If you decide to trade Quick Heal Technologies, use the lowest-cost* platform that is rated #1 Overall by Barron’s, Interactive Brokers. Trade stocks, options, futures, forex, bonds and funds on 135 markets, all from a single integrated account. Promoted


Valuation is complex, but we're here to simplify it.

Discover if Quick Heal Technologies might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.

About NSEI:QUICKHEAL

Quick Heal Technologies

Engages in the provision of security software products and solutions to consumers, small businesses, government establishments, and corporate houses in India and internationally.

Flawless balance sheet with slight risk.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0776.3% undervalued
27 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
JA
KO logo
Jades on Coca-Cola ·

Coca-Cola’s Enduring Moat in a Health-Conscious World: Steady Compounder Poised for 5-10% Annual Returns Through Emerging Market Dominance

Fair Value:US$66.221.6% overvalued
15 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
ET
XRO logo
Ethan_cpa on Xero ·

Xero: Growth Was Priced In — Execution Is Not

Fair Value:AU$101.5619.0% undervalued
5 users have followed this narrative
1 users have commented on this narrative
4 users have liked this narrative
KA
NU logo
kabz2342 on Nu Holdings ·

Nu holdings will continue to disrupt the South American banking market

Fair Value:US$64.374.1% undervalued
38 users have followed this narrative
3 users have commented on this narrative
22 users have liked this narrative

Updated Narratives

UN
unknown
CRM logo
unknown on Salesforce ·

Salesforce (CRM) The Agentic Pivot: Salesforce Redefines the SaaS Era

Fair Value:US$25424.5% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
UN
unknown
NVDA logo
unknown on NVIDIA ·

Nvidia (NVDA) The Sovereign of Silicon: Accelerating Beyond the $5 Trillion Horizon

Fair Value:US$248.421.3% undervalued
17 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
JA
STLAP logo
Janpeo on Stellantis ·

IA Analysis

Fair Value:€1138.3% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.886.7% undervalued
65 users have followed this narrative
5 users have commented on this narrative
28 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59632.8% undervalued
1297 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative
TA
Talos
TSLA logo
Talos on Tesla ·

The "Physical AI" Monopoly – A New Industrial Revolution

Fair Value:US$665.3637.3% undervalued
49 users have followed this narrative
20 users have commented on this narrative
22 users have liked this narrative